We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.
- Authors
Rassen, Jeremy A; Mittleman, Murray A; Glynn, Robert J; Alan Brookhart, M; Schneeweiss, Sebastian
- Abstract
To evaluate the effectiveness and safety of bivalirudin as used in routine care. Bivalirudin has been studied as an alternative to heparin plus glycoprotein IIb/IIIa inhibitor (GPI) during percutaneous coronary intervention (PCI). Trials have indicated that bivalirudin is non-inferior to heparin with respect to death and repeat revascularization and may decrease the risk of major bleeds. The use of bivalirudin in routine care has not been evaluated.
- Publication
European heart journal, 2010, Vol 31, Issue 5, p561
- ISSN
1522-9645
- Publication type
Journal Article
- DOI
10.1093/eurheartj/ehp437